The Keosys Blog

Keosys Oct 8, 2024

Interview: Focus on the Scandinavian pharmaceutical market

With her large experience in the pharmaceutical industry, Helen Blanco..

Keosys Dec 15, 2022

Interview: 2022 in Review with Oana Popa-Nita

2022 Year in Review 2022 is coming to a close, and it’s a great time to reflect..

Keosys Dec 14, 2022

The Best Keosys Blogs of 2022

Recap: Top blog posts of 2022 It’s been a great year for Keosys, the..

Keosys Sep 28, 2022

Interview: An Immunotherapeutic Drug Development Expert Discusses Future of Cancer Management

William Le brings nearly 20 years of experience in drug development in oncology..

Keosys Jul 7, 2022

Interview: A Clinical R&D Expert Talks About the Future of Radiopharmaceuticals

With a background in clinical research and development, UK-trained physician..

Keosys Mar 28, 2022

Interview: An Interventional Radiologist Talks About Radioembolization in the Treatment of HCC Today

Dr. Yan Rolland, head of the diagnosis and interventional radiology department..

Keosys Mar 15, 2022

Interview: A Radiology Professor Talks About mRECIST, Reading Images in Clinical Trials, and More

Maxime Ronot, Professor at the Université de Paris, and Radiologist in the..

Keosys Feb 23, 2022

Interview: Keosys Advances into a Promising New Year

With our 20th anniversary year recently completed and a new year underway, we..

Keosys Sep 9, 2021

Interview: A Medical Doctor Finds Her Biotech Home

We recently spoke with Eveline Boucher, MD, Senior Medical Director for Boston..

Keosys Mar 23, 2021

Interview: Cancer Insight Leverages a Surgical Oncologist's Long Commitment to Service and Research

We recently spoke with George E. Peoples, M.D., founder and Chief Executive..

Keosys Feb 19, 2021

Interview: Global Perspectives from a Global Powerhouse, Syneos Health

We recently spoke with Patrick Nealon, Executive Vice President and General..

Keosys Dec 11, 2020

Interview: OncoBay Clinical Redefines What's Possible for CROs

We recently spoke with OncoBay Clinical executives Krystyna Kowalczyk, CEO, and..

All posts Next

Recent